News Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

End-of-day quote Toronto S.E. Other stock markets 06:00:00 2024-04-21 pm EDT			5-day change	1st Jan Change
0.09 ^CAD	0.00%		+5.88%	-10.00%

Apr. 01	Willow Biosciences Narrows 2023 Loss YOY	MT
Mar. 29	Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Willow Biosciences Narrows 2023 Loss YOY	Apr. 01	MT
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	Mar. 28	AQ
Willow Biosciences Announces Second Strategic Investment From Kalsec	Mar. 01	MT
Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient	Feb. 21	MT
Willow Biosciences Inc. announced that it expects to receive funding from Kalsec Inc.	Feb. 19	CI
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	Jan. 31	MT
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	Jan. 31	CI
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	Jan. 31	AQ
Willow Biosciences Announces Collaboration with Active Pharmaceutical Ingredient Manufacturer to Manufacture More Sustainable, Cost-Effective Manufacturing Route for Their Largest Product Sold Globally	Jan. 31	CI
Willow Biosciences Announces Collaboration With Enterin	Jan. 16	MT
Willow Biosciences Inc. Announces Collaboration with Enterin, Inc. to Develop Sustainable Interimates and Active Pharmaceutical Ingredients	Jan. 16	CI
WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	Jan. 16	AQ
Willow Biosciences Highlights Growth Plans for 2024, Provides 2023 Highlights	Jan. 10	MT
Willow Biosciences Brief: Says Plans For "Significant" Growth In 2024	Jan. 10	MT
Willow Bioscience plans to advance development program with Nasdaq-listed company	Dec. 11	AQ
Toronto Stocks Flat; Laurentian Bank of Canada Declines on Lower 4Q Profit, Revenue	Dec. 07	DJ
Willow Biosciences and Nasdaq-listed Biopharma Co Advancing Development Program	Dec. 07	MT
Willow Biosciences Brief: Willow and a Nasdaq-listed biopharma company Advancing Development Program	Dec. 07	MT
Willow Biosciences Reports Q3 Results, Provides Update	Nov. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

Summary

Filters